Evidence map›Paper›PMID 29959371›Full record

ArticleScientific reports2018

Jia-Jian-Di-Huang-Yin-Zi decoction exerts neuroprotective effects on dopaminergic neurons and their microenvironment.

Jingsi Zhang, Zhennian Zhang, Wen Zhang, Xiangting Li, Ting Wu, Tingting Li, Min Cai, Zhonghai Yu, Jun Xiang, Dingfang Cai

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Dihuang-Yinzi Alleviates Cognition DeficitsFrontiers in aging neuroscience · 2022
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jingsi ZhangDepartment of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zhennian ZhangDepartment of Neurology, Nanjing Hospital of Traditional Chinese Medicine, Nanjing, 210000, China.
Wen ZhangDepartment of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Xiangting LiDepartment of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Ting WuDepartment of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Tingting LiDepartment of Neurology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Min CaiDepartment of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zhonghai YuDepartment of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Jun XiangDepartment of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. xiang.jun@mail.zs-hospital.sh.cn.
Dingfang CaiDepartment of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. dingfangcai@163.com.
Fudan University · CNZhongshan Hospital · CNNanjing Traditional Chinese Medicine Hospital · CNShanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a classical prescription of Traditional Chinese medicine, the Jia-Jian-Di-Huang-Yin-Zi (JJDHYZ) decoction has long been used to treat movement disorders. The present study evaluated the effects of JJDHYZ on dopaminergic (DA) neurons and their survival-enhancing microenvironment as well as the possible mechanisms involved using a mouse model of Parkinson's disease. In MPTP-lesioned mice, a high dosage of JJDHYZ (34 g/kg/day) attenuated the loss of DA neurons, reversed the dopamine depletion, and improved the expression of glial-derived neurotrophic factor (GDNF) compared to the untreated model group. JJDHYZ also protected the ultrastructure of the blood-brain barrier (BBB) and tight junction proteins by inhibiting the activation of microglia and astrocytes besides the increase in three types of matrix metalloproteinases in the substantia nigra. In conclusion, the JJDHYZ-high dosage (JJDHYZ-H) group exhibited the neuroprotection of DA neurons, and the underlying mechanism may be related to the survival-enhancing microenvironment of the DA neurons.

Indexed as

AnimalsAntioxidantsAstrocytesBlood-Brain BarrierCellular MicroenvironmentChemokine CCL2Chemokine CCL4Claudin-5Dopaminergic NeuronsDrugs, Chinese HerbalGene Expression RegulationGlial Cell Line-Derived Neurotrophic FactorInterleukin-23Matrix MetalloproteinasesMiceMicrogliaAntioxidantsChemokine CCL2Chemokine CCL4Claudin-5di huang yin ziDrugs, Chinese HerbalGlial Cell Line-Derived Neurotrophic FactorInterleukin-23Matrix MetalloproteinasesNeuroprotective AgentsOccludin

Identifiers

PMID29959371
PMCPMC6026152
OpenAlexW2809794751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.